Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas
Downloads Digital Contract Notes Online Trading Demo News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Alivus Life Sciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 543322 border-img ISIN Demat INE03Q201024 border-img Book Value 229.75 border-img NSE Symbol ALIVUS border-img Div & Yield % 0.45 border-img Market Cap (₹ Cr.) 13496.56 border-img P/E 27.79 border-img EPS 39.6 border-img Face Value 2
ParticularsMar 2024
(₹)		Mar 2023
(₹)		Mar 2022
(₹)		Mar 2021
(₹)		Mar 2020
(₹)		Mar 2019
(₹)
INCOME :       
Sales Turnover 2283.212161.222123.211885.171537.31886.42
Excise Duty 0.000.000.000.000.000.00
Net Sales 2283.212161.222123.211885.171537.31886.42
Other Income 12.0428.9614.700.8111.990.44
Stock Adjustments 56.5784.44-41.3270.704.64301.59
Total Income 2351.822274.622096.591956.681553.941188.45
EXPENDITURE :       
Raw Materials 1025.211068.56977.96948.17668.66633.56
Power & Fuel Cost 112.46115.60100.9274.1976.7557.81
Employee Cost 258.16180.18168.72149.13142.28106.28
Other Manufacturing Expenses 163.64137.17124.04107.32108.0477.09
Selling & Administrative Expenses 64.1265.4748.6448.5042.0544.20
Miscellaneous Expenses 41.9736.3945.5637.4932.2221.35
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 1665.541603.361465.831364.801069.99940.29
Operating Profit 686.29671.25630.76591.89483.96248.17
Interest 1.550.5527.9687.5533.520.61
Gross Profit 684.74670.70602.80504.34450.44247.56
Depreciation 53.4542.0937.8833.3929.3719.26
Profit Before Tax 631.29628.61564.92470.95421.07228.30
Tax 152.21150.61137.63112.7598.5425.90
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 8.1911.048.576.629.436.81
Reported Net Profit 470.89466.96418.72351.58313.10195.59
Extraordinary Items -0.53-0.41-0.55-0.44-0.91-0.54
Adjusted Net Profit 471.42467.37419.27352.02314.01196.13
Adjustment below Net Profit -5.46-0.29-19.50-0.530.47-108.02
P & L Balance brought forward 1102.061021.35750.79399.7386.17-1.41
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 275.69385.96128.650.000.000.00
P & L Balance carried down 1291.801102.061021.35750.79399.7386.17
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 1125.002100.001050.000.000.000.00
Dividend Per Share(Rs) 22.5042.0021.000.000.000.00
Earnings Per Share-Unit Curr 38.4338.1134.17358.761597.44997.92
Earnings Per Share(Adj)-Unit Curr 38.4338.1134.17358.761597.44997.92
Book Value-Unit Curr 190.35174.51167.66768.112049.45449.62
Book Value(Adj)-Unit Curr 190.35174.51167.66768.112049.45449.62

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109, |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and content powered by CMOTS Infotech( ISO 9001:2015 certified )

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
close
refresh